Advanced search
1 file | 833.91 KB

TILs in head and neck cancer : ready for clinical implementation and why (not)?

(2017) HEAD & NECK PATHOLOGY. 11(3). p.354-363
Author
Organization
Abstract
The assessment of tumor infiltrating lymphocytes (TILs) has recently emerged as a prognostic biomarker in several solid tumors. Quantification and subtyping of TILs reflects the immune response in the tumor microenvironment, contributing to either tumoral immune attack or escape and thereby affecting outcome. Despite the growing evidence of its value as prognosticator, TILs analysis has not yet found its way to daily clinical practice. The aim of this review is to evaluate whether the current knowledge on TILs in head and neck cancer justifies its clinical implementation. Therefore, we summarize the data on TILs in squamous cell cancer of the head and neck with focus on the most important subsets (T lymphocytes and more specifically CD8(+) cytotoxic T cells and FoxP3(+) regulatory T cells) and site-specific characteristics such as Human Papilloma Virus infection. In addition, we discuss methodological problems and pitfalls that can account for discordant findings and that may hamper inclusion of TILs assessment in routine practice of pathologists and oncologists.
Keywords
Squamous cell carcinoma of the head and neck, Tumor infiltrating lymphocytes, Prognosis, Biomarker, :REGULATORY T-CELLS, HUMAN-PAPILLOMAVIRUS, EPIDEMIOLOGY CONSORTIUM, INTERNATIONAL HEAD, POOLED ANALYSIS, CHEMORADIOTHERAPY, EQUILIBRIUM, LYMPHOCYTES, CARCINOMA, CIGARETTE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 833.91 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Meulenaere, Astrid, Tijl Vermassen, SANDRINE ASPESLAGH, Katrien Vandecasteele, Sylvie Rottey, and Liesbeth Ferdinande. 2017. “TILs in Head and Neck Cancer : Ready for Clinical Implementation and Why (not)?” Head & Neck Pathology 11 (3): 354–363.
APA
De Meulenaere, A., Vermassen, T., ASPESLAGH, S., Vandecasteele, K., Rottey, S., & Ferdinande, L. (2017). TILs in head and neck cancer : ready for clinical implementation and why (not)? HEAD & NECK PATHOLOGY, 11(3), 354–363.
Vancouver
1.
De Meulenaere A, Vermassen T, ASPESLAGH S, Vandecasteele K, Rottey S, Ferdinande L. TILs in head and neck cancer : ready for clinical implementation and why (not)? HEAD & NECK PATHOLOGY. 2017;11(3):354–63.
MLA
De Meulenaere, Astrid, Tijl Vermassen, SANDRINE ASPESLAGH, et al. “TILs in Head and Neck Cancer : Ready for Clinical Implementation and Why (not)?” HEAD & NECK PATHOLOGY 11.3 (2017): 354–363. Print.
@article{8507193,
  abstract     = {The assessment of tumor infiltrating lymphocytes (TILs) has recently emerged as a prognostic biomarker in several solid tumors. Quantification and subtyping of TILs reflects the immune response in the tumor microenvironment, contributing to either tumoral immune attack or escape and thereby affecting outcome. Despite the growing evidence of its value as prognosticator, TILs analysis has not yet found its way to daily clinical practice. The aim of this review is to evaluate whether the current knowledge on TILs in head and neck cancer justifies its clinical implementation. Therefore, we summarize the data on TILs in squamous cell cancer of the head and neck with focus on the most important subsets (T lymphocytes and more specifically CD8(+) cytotoxic T cells and FoxP3(+) regulatory T cells) and site-specific characteristics such as Human Papilloma Virus infection. In addition, we discuss methodological problems and pitfalls that can account for discordant findings and that may hamper inclusion of TILs assessment in routine practice of pathologists and oncologists.},
  author       = {De Meulenaere, Astrid and Vermassen, Tijl and ASPESLAGH, SANDRINE and Vandecasteele, Katrien and Rottey, Sylvie and Ferdinande, Liesbeth},
  issn         = {1936-055X},
  journal      = {HEAD \& NECK PATHOLOGY},
  language     = {eng},
  number       = {3},
  pages        = {354--363},
  title        = {TILs in head and neck cancer : ready for clinical implementation and why (not)?},
  url          = {http://dx.doi.org/10.1007/s12105-016-0776-8},
  volume       = {11},
  year         = {2017},
}

Altmetric
View in Altmetric